Pinsent Masons advises the UK government on purchase of further 60m doses of Covid-19 vaccines

10 May 2021 | 09:36 am |

Multinational law firm Pinsent Masons has successfully advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.

The team at Pinsent Masons was led by Life Sciences transactions partner Allistair Booth and included Andy Cornforth, Niki Ruprai, Robert Sherville-Payne and Aaron Hope. 

Commenting on the agreement, Allistair Booth, lead partner at Pinsent Masons said:

"This is an important agreement. Access to 60m doses of that vaccine in time for an autumn revaccination programme will hopefully play a key role in protecting the NHS and the most vulnerable people of the UK.


"We are proud to have worked with the UK government on securing this agreement for such an important vaccine at such a crucial time".  

Latest press releases

Show me all press releases

Pinsent Masons wins Construction Team of the Year at the Middle East Legal Awards

Multinational law firm Pinsent Masons has won Construction Team of the Year at the Middle East Legal Awards 2021.

Pinsent Masons collaborates with LifeArc on expert paper to support drug repurposing

Multinational law firm Pinsent Masons has collaborated with medical research charity LifeArc, on a new report offering expert advice, insights and practical tips to charities, researchers and funders hoping to repurpose drugs for other – often rare and fatal – conditions.

Pinsent Masons advises UCL on £300m sustainability bond

Multinational law firm Pinsent Masons has advised University College London (UCL) on its debut issue of £300m 1.625% sustainability bonds due 2061 - the first publicly listed sustainability bonds in the higher education sector.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons collaborates with LifeArc on expert paper to support drug repurposing

Multinational law firm Pinsent Masons has collaborated with medical research charity LifeArc, on a new report offering expert advice, insights and practical tips to charities, researchers and funders hoping to repurpose drugs for other – often rare and fatal – conditions.

Pinsent Masons recruits third partner in Amsterdam hiring life sciences specialist

Multinational law firm Pinsent Masons has recruited Life Sciences partner, Machteld Hiemstra in Amsterdam as it develops its Netherlands-based technology, science and industry (TSI) capabilities.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts